Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-invasive Mapping of Rhythm Disorders

NCT: NCT02647749 · COMPLETED

NCT IDNCT02647749
StatusCOMPLETED
Start Date2015-05-19
Completion2020-05-28

Brief Summary

This current care protocol follows the biomedical research protocol entitled "Non-invasive mapping of the heart ECG high amplification" that demonstrated the clinical value of noninvasive Cardioinsight® mapping system. Guide the management of patients hospitalized for cardiac rhythm radiofrequency ablation of cardiac arrhythmias, implantation or programming of a pacemaker, or assess the risk of serious arrhythmias or sudden death, with the currently used non-invasive mapping routine. The results obtained with non-invasive mapping will be compared with those obtained with the conventional method without non-invasive mapping.

Frequently Asked Questions

What is Non-invasive Mapping of Rhythm Disorders?

Non-invasive Mapping of Rhythm Disorders is a clinical trial registered under NCT02647749. Current status: COMPLETED.

What is the status of NCT02647749?

The current status of NCT02647749 (Non-invasive Mapping of Rhythm Disorders) is: COMPLETED.

When did Non-invasive Mapping of Rhythm Disorders start?

Non-invasive Mapping of Rhythm Disorders started on 2015-05-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.